Organon & (OGN)

搜索文档
 欧加隆中国总裁吴泽发:坚定“立中国,惠中国,益世界”,将继续加大在中国的投资
 中国新闻网· 2025-10-30 15:01
欧加隆中国总裁吴泽发:坚定"立中国,惠中国,益世界",将继续加大在中国的投资 进入中国5个年头,连续四年参加进博会,欧加隆的"中国情结"不言而喻。 欧加隆中国区总裁吴泽发说,公司以"立中国、惠中国、益世界"为清晰指引,这既源于其对中国的深厚 感情,也构成了其本土化战略的宏伟蓝图。目前,欧加隆在中国的业务涵盖九个治疗领域,包括心血 管、妇科与生育调节、生殖、皮肤、疼痛、呼吸、男性健康、骨健康和中枢神经,在华业务是欧加隆全 球业务中非常重要和关键的一部分。 将加大对中国创新药早期资产的深入考察 2025年前9个月,中国创新药BD(商务拓展)出海在全球创新药中的项目数量占比超过15%,披露总金额 占比超过50%。 吴泽发2018年来到中国时,中国的创新药尚处于萌芽阶段。过去6年多时间里,他切身感受到中国医药 创新领域日新月异的变化。欧加隆也是这波浪潮里的深度参与者。 吴泽发说,从多家药企在中国境内的合作项目规模、收购的资产以及这些资产的潜在价值可以看出,中 国创新资产具备高价值。现在各个跨国药企都公认中国创新生态系统的价值,这已经不是什么秘密了。 在2025年的BD交易热潮下,欧加隆中国已经敲定了一个合作项目,并且 ...
 The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products
 Seeking Alpha· 2025-10-29 02:06
Nationally ranked stock picker for 30 years. Victory Formation and Bottom Fishing Club quant-sort pioneer.....Paul Franke is a private investor and speculator with 39 years of trading experience. Mr. Franke was Editor and Publisher of the Maverick Investor® newsletter during the 1990s, widely quoted by CNBC®, Barron’s®, the Washington Post® and Investor’s Business Daily®. Paul was consistently ranked among top investment advisors nationally for stock market and commodity macro views by Timer Digest® during  ...
 Organon(OGN.US)因内部控制问题重挫,再遭Piper Sandler大砍目标价至5美元
 智通财经网· 2025-10-28 15:01
此次评级下调表明,Piper Sandler认为Organon的复苏之路漫长,这主要是由于需要恢复内部控制和投资 者信心。分析师们还提醒投资者,鉴于当前的不确定性以及该公司扭亏为盈的过程将会既漫长又充满挑 战,风险和波动性可能会加剧。 智通财经APP获悉,Piper Sandler将Organon(OGN.US)的评级从"增持"下调至"减持",并将目标股价从 18 美元下调至 5 美元。此次行动是在审计委员会对公司进行调查之后采取的,该调查揭露了公司在其 避孕产品"Nexplanon"方面存在重大内部控制缺陷,导致 2022 年、2024 年和 2025 年的财务报表出现错 误陈述。周一,该公司股价收跌约23%。 ...
 Organon & Co. (OGN) Faces Investor Scrutiny Amid Improper Wholesale Sales Practices, Abrupt CEO Departure -- Hagens Berman
 Globenewswire· 2025-10-28 06:22
SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- On October 27, 2025, investors in Organon & Co. (NYSE: OGN) saw the price of their shares plummet $2.10 (-23%) after the company announced the findings of its Audit Committee's investigation into improper wholesale sales practices for Nexplanon and CEO Kevin Ali's resignation. The development and severe market reaction has prompted national shareholders rights firm Hagens Berman to open an investigation into whether Organon and its now-former CEO intentionall ...
 Stock Market Today: Nasdaq, S&P, and Dow Post New Records On China Trade Optimism, Strong U.S. Earnings
 Yahoo Finance· 2025-10-27 23:43
 市场开盘表现 - 纳斯达克指数上涨1.47%至8532.62点,标普500指数上涨0.91%至23546.16点,均创下开盘新纪录 [2] - 道琼斯工业平均指数上涨0.66%或310点,至47517.13点 [2] - 罗素2000指数上涨0.53%但随后出现回落 [2]   盘前交易异动 - Janus Henderson因收购传闻股价上涨14%,Darling Ingredients上涨14%,Keurig Dr Pepper在公布业绩后上涨9.7% [4] - Organon & Co因首席执行官在争议中辞职股价下跌21%,Carter's Inc因业绩下跌9.4%,Newmont Corp因金价下跌而下跌5.1% [4]   市场背景与驱动因素 - 美国股指期货上涨,得益于上周的强劲收盘,因优质企业财报和低于预期的通胀报告提振投资者情绪 [5] - 标普500和纳斯达克综合指数上周创下盘中新高,分别突破6800点和23200点,道琼斯工业平均指数亦跃升至47200点以上 [5] - 美国与中国在贸易谈判上取得进展,就芬太尼、稀土金属和高额关税等议题达成框架协议,双方领导人预计将在亚太经合组织会议期间会晤 [6]   今日财报焦点 - 本周是财报季最繁忙的一周,今日将公布业绩的公司包括Welltower、Cadence Design和Waste Management [7] - 盘前已公布业绩的Keurig Dr Pepper股价大幅上涨 [4][7]
 Organon CEO Kevin Ali to resign after probe into wholesaler sales practices
 Reuters· 2025-10-27 19:44
Organon said on Monday CEO Kevin Ali will resign from his role and be replaced by Joseph Morrissey on an interim basis, after an internal investigation into wholesaler sales practices for its Nexplano... ...
 Organon: Muted H2 2025, But Distressed Valuation And Manageable Debt Makes It A Buy (OGN)
 Seeking Alpha· 2025-10-17 19:10
I last wrote about Organon (NYSE: OGN ) back in June , prior to its second-quarter 2025 results, and since then, the company's stock has moved nowhere but sideways. The results presented for the second quarter were slightlyI am a value focused investor, conducting fundamental research on sectors like but not limited to chemicals, homebuilders, building materials, industrials and metals & mining. I prefer to invest in stocks which are cheaply available and have a catalyst in the near future. My investment ho ...
 Organon: Muted H2 2025 Ahead, But Distressed Valuation And Manageable Debt Makes It A Compelling Buy
 Seeking Alpha· 2025-10-17 19:10
I last wrote about Organon (NYSE: OGN ) back in June , prior to its second-quarter 2025 results, and since then, the company's stock has moved nowhere but sideways. The results presented for the second quarter were slightlyI am a value focused investor, conducting fundamental research on sectors like but not limited to chemicals, homebuilders, building materials, industrials and metals & mining. I prefer to invest in stocks which are cheaply available and have a catalyst in the near future. My investment ho ...
 中国驻美国大使谢锋会见欧加隆公司首席执行官黎恺文
 证券时报网· 2025-10-17 07:39
 公司动态 - 欧加隆公司首席执行官黎恺文于2025年10月15日会见了中国驻美国大使谢锋 [1]   行业合作 - 双方就中美医疗健康领域合作交换了意见 [1]   宏观背景 - 会谈涉及中美经贸关系 [1]
 Orogen Royalties Creates a Royalty on the Firenze Gold Project
 Accessnewswire· 2025-10-14 19:30
VANCOUVER, BC / ACCESS Newswire / October 14, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce that it has signed a purchase and sale agreement (the "Agreement") with a wholly owned subsidiary of Altitude Minerals Ltd. (ASX:ATT) ("Altitude") whereby Altitude has acquired the Firenze gold project ("Firenze" or the "Project"), located in Nevada USA. ...







